Keep yourself up to date
Scientists in the UW IPD and David Baker’s lab there have been designing mini-proteins up to 120 residues over the last few years, in a slew of exciting research papers in protein design. Now for the first time they’ve designed short cyclic peptides in the range 18-47 residues — constrained for example by N to […]
Xconomy hosted Cyrus, Prof. David Baker of the University of Washington’s IPD, and founders of two other spin-outs from the IPD, Virvio and PVP Biologics, at their EXOME mini-symposium in Seattle. Geekwire gives a great summary of the current state of computational protein design.
Seattle, WA, April 1 2016. Cyrus Biotechnology is proud to announce a major step forward in computer biochemistry, the ROSVAC-2, an industrial-strength minicomputer custom-designed for simulations of biological molecules, with an astonishingly small 2000 sq ft. footprint, capable of over 5 simultaneous protein amino acid sequence calculations per annum. Data is input into ROSVAC-2 using […]
Cyrus offers an easy-to-use cloud pipeline using SparksX software package to accelerate drug development Seattle, and Indianapolis, October 8, 2015 – Cyrus Biotechnology has signed a software licensing agreement with Indiana University Research and Technology Corporation (IURTC) at Indiana University (IU) to commercialize the SparksX software package developed at the lab of former IU professor […]
Cyrus is thrilled to announce the addition of Rosario Caltabiano to our Executive Team as Executive VP of Sales. Rosario is a fervent customer advocate and successful professional with a high level of integrity. He brings over fifteen years of experience in sales and management with a consistent and successful growth track record, having worked […]